ReviewFrontiers in public health2022

Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review.

Zhi-Kai Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.